红星资本局10月29日消息,10月28日晚,国家医保局公布第十一批国家组织药品集中带量采购拟中选结果。本次集采共纳入55种药品,覆盖抗感染、抗过敏、抗肿瘤、降血糖、降血压、降血脂、消炎镇痛等领域常用药品,共有445家企业的794个产品参与投标,其中272家企业的453个产品获得拟中选资格。红星资本局注意到,本次集采纳入药品不乏外界颇为关注的经典抗流感病毒药物磷酸奥司他韦颗粒剂与临床常用降糖药达格...
Source Link红星资本局10月29日消息,10月28日晚,国家医保局公布第十一批国家组织药品集中带量采购拟中选结果。本次集采共纳入55种药品,覆盖抗感染、抗过敏、抗肿瘤、降血糖、降血压、降血脂、消炎镇痛等领域常用药品,共有445家企业的794个产品参与投标,其中272家企业的453个产品获得拟中选资格。红星资本局注意到,本次集采纳入药品不乏外界颇为关注的经典抗流感病毒药物磷酸奥司他韦颗粒剂与临床常用降糖药达格...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.